Dementia, Delirium, and Other Cognitive Disorders

Psychiatry: Third Edition

Volumn 1, Issue , 2008, Pages 897-930

  Frierson, Robert L ^a   First, Michael B ^b,c,d  

^a University of Louisville School of Medicine   (United States)

^b Columbia University ^*  (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^d NewYork Presbyterian Hospital   (United States)

Author keywords

Alzheimer's disease and dementia cause; Creutzfeldt Jakob disease in memory loss; Delirium, dementia, and amnestic and other cognitive disorders; Dementia and Huntington's disease; Dementia and Parkinson's disease; Mental Status Examination and dementia etiology; Pick's disease and progressive dementia; Sleep wakefulness disturbances; Substance induced persisting dementia; Vascular dementia and multiple CVAs

Indexed keywords

EID: 77957108082     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470515167.ch51     Document Type: Chapter

References (149)

1. Bachman DL, Wolf PA, Linn R, et al. (1992) Prevalence of dementia of probable presenile dementia of the Alzheimer type in the Farmingham study. Neurology 42, 115-119.
2. nd edition. Springer-Verlag, New York, USA.
3. Bettinger TL, Mendelson SC, Dorson PG, et al. (2000) Olanzapine-induced glucose dysregulation. Annals of Pharmacotherapy 34, 865-867.
4. Bick KL (1994) Early story of Alzheimer's disease. In Alzheimer's Disease, Terry RD, Katzman R, and Bick KL (eds). Raven Press, New York, USA.
5. Black PM (1980) Idiopathic normal-pressure hydrocephalus: Result of shunting in 62 patients. Journal of Neurosurgery 52, 371-377.
6. Blass J, Gleason P, Brush DPD, et al. (1988) Thiamine and Alzheimer's disease. Archives of Neurology 45, 833-835.
7. Bond MR (1986) N euro behavioral sequelae of closed head injury. In Neuropsychological Assessment of Neuropsychiatric Disorders, Adams G and Adams KM (eds). Oxford University Press, New York, USA.
8. Brenner RP (1985) The electroencephalogram in altered states of consciousness. Neurologic clinics 3, 615-631.
9. Burger PC and Vogel FS (1973) The development of the pathologic changes of Alzheimer's disease and senile dementia in patients with Down's syndrome. American Journal of Pathology 73, 457-476.
10. Byrne A and Kirby B (1990) The neurotoxicity of inhaled toluene (letter). Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 35, 282.
11. Cameron DE (1941) Studies in senile nocturnal delirium. Psychiatric Quarterly 15, 47-53.
12. Carter JG (1986) Intravenous haloperidol in the treatment of acute psychosis. American Journal of Psychiatry 143, 1316-1317.
13. Cartwright GE (1978) Diagnosis of treatable Wilson's disease. New England Journal of Medicine 298, 1347-1350.
14. Chung YS, Ravi SD, and Borge GF (1986) Psychosis in Wilson's disease. Psychosomatics 27, 65-66.
15. Cole MG (2004) Delirium in elderly patients. American Journal of Geriatric Psychiatry 12 (1), 7-21.
16. Corder EH, Saunder AM, Strittmatten WJ, et al. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923.
17. Cotman CW and Pike CJ (1994) Beta amyloid and its contributions to neurodegeneration in Alzheimer's disease. In Alzheimer's Disease, Terry RD, Katzman R, and Bick KL (eds). Raven Press, New York, USA, pp 305-317.
18. Crapper DR and Dalton AJ (1972) Alterations in short-term retention, conditioned avoidance response, acquisition and motivation following aluminum-induced neurofibrillary degeneration. Physiology and Behavior 10, 925-933.
19. Cummings JL and Benson DF (1983) Dementia: A Clinical Approach. Butterworth, Boston, MA, USA.
20. Delacourte A and Defossez A (1986) Alzheimer's disease: Tau proteins, the promoting factors of microtubule assembly are major components of paired helical filaments. Journal of Neuroscience 76, 173-186.
21. Dollken V (1897) Ueber die Wirkung des Aluminums mit besonderer Berucksichtigung der durch das Aluminum verusachten. Lasionem in zentral Nervensystem. Archiv fuer experimentelle Pathologie und Phar-makologie 40, 98-120.
22. Eisendrath SJ, Goldman B, Douglas J, et al. (1987) Meperidine-induced delirium. American Journal of Psychiatry 144, 1062-1065.
23. Engel GL and Roman J (1959) Delirium: A syndrome of cerebral insufficiency. Journal of Chronic Diseases 9, 260-277.
24. Erkinjuntii T, Wikstrom J, Paolo J, et al. (1986) Evaluation of 2000 consecutive admissions. Archives of Internal Medicine 146, 1923-1926.
25. Errebo-Knudson EO and Olsen F (1986) Organic solvents and presenile dementia (the painter's syndrome): A critical review of the Danish literature. Science of the Total Environment 48, 45-67.
26. Evans DA (1990) Estimated prevalence of Alzheimer's disease in the United States. Milbank Quarterly 68, 276-289.
27. Fernandez F, Holmes VF, Adams F, et al. (1988) Treatment of severe, refractory agitation with a haloperidol drip. Journal of Clinical Psychology 49, 239-241.
28. Ferris SH, Sathananthan G, Gershon S, et al. (1976) Cognitive effect of ACTH 4-10 in the elderly. Neuropeptides 5, 73-78.
29. Fick DM, Kolanowski AM, Waller JI, et al. (2005) Delirium superimposed on dementia in a community-dwelling managed care population. Journal of Gerontology 60 (6), 748-753.
30. th edition. American Psychiatric Association, Washington, DC, USA, pp 123-174.
31. Fisher CM (1982) Hydrocephalus as a cause of gait disturbance in the elderly. Neurology 32, 1358-1363.
32. Fisher CM and Adams RD (1964) Transient global amnesia. Acta Neuro-logica Scandinavica 39, 605-608.
33. Foreman MD and Milisen K (2004) Improving recognition of delirium in elderly. 11 (11), 46-50.
34. Francis J, Martin D, and Kapoor W (1990) A prospective study of delirium in hospitalized elderly. JAMA: The Journal of the American Medical Association 263, 1097-1101.
35. Friedman JH (2006) Atypical antidepressants in the elderly with Parkinson's Disease and the "black box" warning. Neurology 67 (4), 564-566.
36. Frierson RL, Wey JJ, and Tabler JB (1991) Psychostimulants for depression in the medically ill. American Family Physician 43, 163-170.
37. Ganrot PO (1986) Metabolism and possible health effects of aluminum. Environmental Health Perspectives 65, 363-441.
38. Garquonine PG (1991) Learning in post-traumatic amnesia following extremely severe closed head injury. Brain Injury 5, 169-174.
39. Gelfand SB, Indelicato J, and Benjamin J (1992) Using intravenous Haldol to control delirium. Hospital and Community Psychiatry 43, 215.
40. Glassman A and Bigger J (2001) Antipsychotic drugs: Prolonged Qtc interval, torsades de pointes, and sudden death. American Journal of Psychiatry 158, 1774-1782.
41. Grabski DA (1961) Toluene Sniffing producing cerebellar degeneration. American Journal of Psychiatry 118, 461-462.
42. Graver DL (2000) Review of quetiapine side effects. Journal of Clinical Psychiatry 61, 31-33.
43. Grundke-Igbal I, Igbal K, Quinlan M, et al. (1986) Microtubule-associated protein tau: A component of paired helical filaments. Journal of Biological Chemistry 261, 6084-6089.
44. Hanson MR and Galvez-Jimenez N (2004) Management of dementia and acute confusional states in the perioperative period. Neurologic Clinics 22 (2) 413-422.
45. Henderson AS (1990) Epidemiology of dementia disorders. Advances in Neurology 51, 15-25.
46. Henderson VW, Roberts E, Wimer C, et al. (1989) Multicenter trial of naloxone in Alzheimer's disease. Annals of Neurology 25, 404-406.
47. Hershey LA, Modic MT, Greenough PG, et al. (1987) Magnetic resonance imaging in vascular dementia. Neurology 37, 29-36.
48. Heyman A, Fillenbaum G, Prosnitz B, et al. (1991) Estimated prevalence of dementia among elderly black and white community residents. Archives of Neurology 48, 594-599.
49. Ho D, Bredesen DE, Vinters HV, et al. (1987) AIDS dementia complex. Annals of Internal Medicine 2, 400-409.
50. Hodges JR and Warlow CP (1990) The etiology of transient global amnesia: A case-control study of 114 cases with prospective follow-up. Brain 113, 639-657.
51. Hyman BT, Eslinger PJ, and Damasio A (1985) Effect of naltrexone in senile dementia of the Alzheimer type. Journal of Neurology, Neurosurgery and Psychiatry 48, 1169-1171.
52. Jenike MA, Albert MS, Heller H, et al. (1986) Combination therapy with lecithin and ergoloid mesylates for Alzheimer's disease. Journal of Clinical Psychiatry 47, 249-251.
53. Jordan BD (1987) Neurologic aspects of boxing. Archives of Neurology 44, 453-459.
54. Kallmann MH (1989) Mental status assessment in the elderly. Primary Care; Clinics in Office Practice 16, 329-347.
55. th edition. Williams & Wilkins, Baltimore, MD, USA.
56. Karp H (1984) Dementia in adults. In Clinical Neurology, Vol 3, Baker AB and Baker LH (eds). Harper & Row, New York, USA, pp 1-32.
57. Katzman R (1994) Apolipoprotein E4 as the major genetic susceptibility factor for Alzheimer's disease. In Alzheimer's Disease, Terry RD, Katz-man R, and Bick KL (eds). Raven Press, New York, USA, pp 455-457.
58. Katzman R and Kawas C (1994) Epidemiology of dementia and Alzheimer's disease. In Alzheimer's Disease, Terry RD, Katzman R, and Bick KL (eds). Raven Press, New York, USA, pp 105-123.
59. Kaufman D (1990a) Aphasia and related disorders. In Clinical Neurology for Psychiatrists. WB Saunders. Philadelphia, PA, USA. pp 146-171.
60. Kaufman D (1990b) Dementia. In Clinical Neurology for Psychiatrists. WB Saunders, Philadelphia, PA, USA, pp 107-146.
61. rd edition. WB Saunders, Philadelphia, PA, USA, pp 358-410.
62. Kidd M (1963) Paired helical filaments in electron microscopy of Alzheimer's disease. Nature 197, 192-193.
63. Kirk T, Roache JD, and Griffiths RR (1990) Dose-response evaluation of the amnestic effects of triazolam and pentobarbital in normal subjects. Journal of Clinical Psycho pharmacology 10, 160-167.
64. Kiatzo I, Wisniewski N, and Streicher E (1965) Experimental production of neurofibrillary degeneration. I. Light microscopic observation. Journal of Neuropathology and Experimental Neurology 24, 187-199.
65. Knox JW and Nelson JR (1966) Permanent encephalopathy from toluene inhalation. New England Journal of Medicine 275, 1494-1496.
66. Korvath T, Siever L, Mohs R, et al. (1989) Organic mental syndromes and disorders. In Comprehensive Textbook of Psychiatry V, Vol I, Kaplan H and Sadock B (eds). Williams & Wilkins, Baltimore, MD, USA, pp 599-642.
67. Kriwisky M, Perry G, Tarchitsky D, et al. (1990) Haloperidol-induced torsades de pointes. Chest 94, 482-484.
68. Lerner D, Schuetz L, Holland S, et al. (2000) Low dose Risperidone for the irritable medically ill patient. Psychosomatics 41, 69-71.
69. nd edition. Oxford University Press, New York, USA.
70. Lipowski ZJ (1982) Differentiating delirium from dementia in the elderly Clinical Gerontologist 1, 3-10.
71. Lipowski ZJ (1983) Transient cognitive disorders (delirium, acute confu-sional states) in the elderly. American Journal of Psychiatry 140 1426-1436.
72. Lipowski ZJ (1987) Delirium (acute confusional states). JAMA: The Journal of the American Medical Association 258, 1789-1792.
73. Lipowski ZJ (1989) Delirium in the elderly patient. New England Journal of Medicine 320, 578-582.
74. Lipowski ZJ (1990) Delirium: Acute Confusional States. Oxford University Press, New York, USA.
75. Mamo D, Sweet R, Mulsant B, et al. (2002) Neuroleptic-induced parkinsonism in Alzheimer's disease. Psychiatric Annals 32, 249-252.
76. Markesbery WR and Ehmann WD (1994) Brain trace elements in Alzheimer's disease. In Alzheimer's Disease, Terry RD, Katzman R, and Bick KL (eds). Raven Press, New York, USA.
77. Marzewski DJ, Towfighi J, Harrington MG, et al. (1988) Creutzfeldt-Jakob disease following pituitary-derived human growth hormone therapy: A new American case. Neurology 38, 1131-1133.
78. Massie M, Holland J, and Glass E (1983) Delirium in terminally ill cancer patients. American Journal of Psychiatry 140, 1048-1050.
79. Mawdsley C and Fergusen FR (1953) Neurologic disease in boxers. Lancet 2, 795-801.
80. McNicoll L, Pisani MA, and Zhang Y (2003) Delirium in the intensive care unit. Occurrence and clinical course in older patients. Journal of the American Geriatrics Society 51 (5), 591-598.
81. Melo TP, Ferro JM, and Ferro H (1992) Transient global amnesia: A case control study. Brain 115, 261-270.
82. Menza MA, Murray GB, Holmes VF, et al. (1987) Decreased extrapyrami-dal symptoms with intravenous Haldol. Journal of Clinical Psychology 48, 278-280.
83. Mohs RC, Davis BM, Johns CA, et al. (1985) Oral physostigmine in treatment of patients with Alzheimer's disease. American Journal of Psychiatry 142, 28-33.
84. Mortell EJ (1946) Idiopathic hypoparathyroidism with mental deterioration: Effect of treatment of intellectual function. Journal of Clinical Endocrinology 6, 266-271.
85. Moss AJ (1993) Measurement of the QT interval and the risk associated with Qtc interval prolongation: A review. American Journal of Cardiology 72, 23B-25B.
86. Muralee S, Bober D, and Tampi R (2004) Delirium in the COX-2 inhibitor Refecoxib. Psychosomatics 45 (4), 361-363.
87. Nolan K, Black R, Langberg J, et al. (1991) A trial of thiamine in Alzheimer's disease. Archives of Neurology 48, 81-83.
88. Nukina N and Ihara Y (1986) One of the antigenic determinants of paired helical filaments is related to tau protein. Journal of Biochemistry 99, 1541-1544.
89. Obrecht R, Okhomina FOA, and Scott DF (1979) Value of EEG in acute confusional states. Journal of Neurology, Neurosurgery and Psychiatry 42, 75-77.
90. Osser DN, Najarjan DM, and Dufresne RL (1999) Olanzapine increases weight and serum triglyceride levels. Journal of Clinical Psychiatry 60, 767-770.
91. Pajeau AK and Roman G (1992) HIV encephalopathy and dementia. Psychiatric Clinics of North America 15, 455-466.
92. Perl DP and Good PF (1987) Uptake of aluminum in central nervous system along nasal-olfactory pathways. Lancet 1, 1028.
93. Peterson P (1968) Psychiatric disorders in primary hyperparathyroidism. Journal of Clinical Endocrinology 28, 1491-1496.
94. Pettegrew JW, McClure RJ, and Kanfer JN (1994) The role of membranes and energetics in Alzheimer's disease. In Alzheimer's Disease, Terry RD, Katzman R, and Bick KL (eds). Raven Press, New York, USA, pp 369-387.
95. Plum F, Posner JB, and Hain RF (1962) Delayed neurological deterioration after anoxia. Archives of Internal Medicine 110, 18-25.
96. Pro JD and Well CE (1977) The use of the electroencephalogram in the diagnosis of delirium. Diseases of the Nervous System 38, 804-808.
97. Prusiner SB (1987) Prions and neurodegenerative diseases. New England Journal of Medicine 317, 1571-1581.
98. Rappaport EB and Graham DJ (1987) Pituitary growth hormone from human cadavers: Neurologic disease in 10 recipients. Neurology 37, 1211-1213.
99. Reulen JB, Girard DE, and Cooney TG (1985) Wernicke's encephalopathy New England Journal Of Medicine 312, 1035-1039.
100. Ross R, Smith G, and Guggenheim F (1990) Neurosyphilis and organic mood syndrome: A forgotten diagnosis. Psychosomatics 31, 448-450.
101. Saito T (1987) Presenting symptoms and natural history of Wilson's disease. European Journal of Pediatrics 146, 261-265.
102. Saneda DL and Corrigan JD (1992) Predicting clearing of post-traumatic amnesia following closed head injury. Brain Injury 6, 167-170.
103. Scharko AM, Baker EH, and Kothari P (2006) Case study: Delirium in an adolesecent girl with human immunodeficiency virus-associated dementia. Journal of the American Academy of Child and Adolescent Psychiatry 45 (1) 104-108.
104. Scharnhorst S (1992) AIDS dementia complex in the elderly: Diagnosis and management. Nurse Practitioner 17, 41-43.
105. Scherp HW and Church CF (1937) Neurotoxin action of aluminum salts. Proceedings of the Society for Experimental Biology and Medicine 36, 851-853.
106. Schneider F, Bonner H, Habel V, et al. (2002) Risk factors for postop delirium in vascular surgery. General Hospital Psychiatry 24, (1), 28-34.
107. Schneider LS, Dagerman KS, and Insel P (2005) Risk of death with atypical drug treatment for dementia. JAMA: The Journal of the American Medical Association 294, (15), 1934-1943
108. Sipahimalani A and Massand P (1997) Use of Risperidone in delirium: Case reports. Annals of Clinical Psychiatry 9, 105-107.
109. Sipahimalani A and Massand P (1998) Olanzapine in the treatment of delirium. Psychosomatics 39, 422-429.
110. Slaby AE and Erle SR (1993) Dementia and delirium. In Psychiatric Care of the Medical Patient, Stoudemire A (ed). Oxford University Press, New York, USA, pp 415-455.
111. Sominen H, Koskinen T, Helkala E-L, et al. (1985) Treatment of Alzheimer's disease with a synthetic ACTH: 4-9 analog. Neurology 35, 1348-1351.
112. Starosta-Rubinstein S, Young AB, Kiuin K, et al. (1987) Clinical assessment of 31 patients with Wilson's disease. Archives of Neurology 44 365-370.
113. Steinhart MJ (1983) The use of haloperidol in geriatric patients with organic mental disorder. Current Therapeutic Research 33, 132-143.
114. Summergrad P, Rach S, and Neal RR (1993) Human immunodeficiency virus and other infectious disorders affecting the central nervous system. In Psychiatric Care of the Medical Patient, Stroudemire A and Fogel BS (eds). Oxford University Press, New York, USA.
115. Summers WK, Majorski LV, March GM, et al. (1986) Oral tetrahydroami-noacridine in long-term treatment of senile dementia, Alzheimer type. New England Journal of Medicine 315, 1241-1245.
116. Tariot P, Cohn R, Sunderland T, et al. (1987) l-Depenyl in Alzheimer's disease. Archives of General Psychiatry 44, 427-433.
117. Tarter RE and Schneider DU (1976) Blackouts: Relationship with memory capacity and alcoholism history. Archives of General Psychiatry 33, 1492-1495.
118. Terry RD, Katzman R, and Bick KL (eds) (1994) Alzheimer's Disease. Raven Press, New York, USA, pp 65-74.
119. Tesar GE, Murray GB, and Cassen NH (1985) Use of intravenous Haldol in the treatment of agitated cardiac patients. Journal of Clinical Psychopharmacology 5, 344-347.
120. Teste D, Okamota A, Napolitano J, et al. (2000) Low incidence of persistent tardive dyskinesia in elderly patients treated with Risperidone. American Journal of Psychiatry 157, 1150-1155.
121. Thal L (1994) Clinical trials in Alzheimer's disease. In Alzheimer's Disease, Terry RD, Katzman R, and Bick KL (eds). Raven Press, New York, USA, pp 431-445.
122. Theobald D (1977) Delirium: Definition, evaluation, and management in the critically ill patient. Indiana Medicine 80, 526-528.
123. Tobias CR, Turms DM, and Lippmann SB (1988) Psychiatric disorders in the elderly: Psychopharmacologic management. Journal of Postgraduate Medicine 83, 313-319.
124. Torres R, Mittal D, and Kennedy R (2001) Use of quetiapine in delirium. Psychosomatics 42, 347-349.
125. Tran P, Hamilton S, Kuntz A, et al. (1997) Double-blind comparison of Olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders. Journal of Clinical Psychopharmacology 17, 417-418.
126. nd edition. FA Davis, Philadelphia, PA, USA.
127. th edition, Wintrobe MM, Thron GW, and Adams RD (eds). McGraw-Hill, New York, USA, pp 100-110.
128. Weddington WW (1982) The mortality of delirium: An underappreciated problem? Psychosomatics223, 1232-1235.
129. Wilkins RH and Brody IA (1969) Neurological classics. XX: Alzheimer's disease. Archives of Neurology 21, 109-115.
130. th edition, Wilson JD, Braunwald E, Issel-bacher KJ, et al. (eds). McGraw-Hill, New York, USA, pp 474-477.
131. Wisniewski HM, Narang HK, and Terry RD (1976) Neurofibrillary tangles of paired helical filaments. Journal of the Neurological Sciences 27, 173-181.
132. Wolf JK (1980) Practical Clinical Neurology. Medical Examination Publishing, Garden City, NY, USA.
133. Wolfson LI and Katzman R (1983) The neurological consultation at age 80. In Neurology of Aging, Katzman R and Terry RD (eds). FA Davis, Philadelphia, PA, USA, pp 221-244.
134. Ziber N, Rannon L, Alter M, et al. (1983) Measles, measles vaccination, and risk of subacute sclerosing panencephalitis (SSPE). Neurology 33, 1558-1564.
135. Adams F (1988) Emergency intravenous sedation of delirious medically ill patients. Journal of Clinical Psychology 48 (suppl), 22-27.
136. AIDS Surveillance Report (2002) Centers for Disease Control, February.
137. t h edition. APA, Washington DC, pp 123-174.
138. Annau Z (1981) The neurobehavioral toxicity of trichloroethylene. Neurobehavioral Toxicology and Teratology 3, 417-424.
139. Azim W and Walker R (2003) Wernicke's encephalopathy: A frequently missed problem. Hospital Medicine 64, (6), 326-327.
140. Benson DF, LeMay M, Patten DH, et al. (1970) Diagnosis of normal pressure hydrocephalus. New England Journal of Medicine 283, 609-615.
141. Black DW, Wanack G, and Winokur G (1985) The Iowa record linkage study II: Excess mortality among patients with organic mental disorders. Archives of General Psychiatry 42, 78-81.
142. Cummings JL (1988) Organic psychosis. Psychosomatics 29, 16-26.
143. Erkinjuntii T (1999) Cerebrovascular dementia: pathophysiology, diagnosis, and treatment. CNS Drugs 12, 35-48.
144. Foltz EL and Ward AA Jr (1956) Communicating hydrocephalus from subarachnoid bleeding. Journal of Neurosurgery 13, 546-566.
145. Jukina N and Ihara Y (1986) One of the antigenic determinants of paired helical filaments is related to tau protein. Journal of Biochemistry 99, 1541-1544.
146. Kalaria RN and Ballard C (1999) Overlap between pathology of Alzheimer's disease and vascular dementia. Alzheimers Disease and Associated Disorders 13 (suppl), 115-123.
147. Lechtenberg R (1982) The Psychiatrist's Guide to Diseases of the Nervous System. John Wiley, New York, USA.
148. Lipowski ZJ (1975) Sensory and information inputs overload: Behavioral effects. Comprehensive Psychiatry 16, 199-221.
149. Marx JA (1985) The varied faces of Wernicke's encephalopathy. Journal of Emergency Medicine 3, (5), 411-413.